ECMO after cardiac surgery: a single center study on survival and optimizing outcomes

Abstract

Background The study purpose is to examine survival prognostic and extracorporeal membrane oxygenation (ECMO) application outcomes at our tertiary care center. Methods This is a retrospective analysis, January 2014 to September 2019. We analyzed 60 patients who underwent cardiac surgery and required peri-operative ECMO. All inpatients with demographic and intervention data was examined. 52 patients (86.6%) had refractory cardiogenic shock, 7 patients (11.6%) had pulmonary insufficiency, and 1 patient (1.6%) had hemorrhagic shock, all patients required either venous-arterial (VA) (n\u2009=\u200953, 88.3%), venous-venous (VV) (n\u2009=\u20095, 8.3%) or venous-arterial-venous (VAV) (n\u2009=\u20092, 3.3%) ECMO for hemodynamic support. ECMO parameters were analyzed and common postoperative complications were examined in the setting of survival with comorbidities. Results In-hospital mortality was 60.7% (n\u2009=\u200937). Patients who survived were younger (52\u2009±\u20093.3 vs 66\u2009±\u20091.5, p\u2009<\u20090.001) with longer hospital stays (35\u2009±\u20094.0 vs 20\u2009±\u20091.5, p\u2009<\u20090.03). Survivors required fewer blood products (13\u2009±\u20092.3 vs 25\u2009±\u20092.3, p\u2009=\u20090.02) with a net negative fluid balance (−\u20093.5\u2009±\u20091.6 vs 3.4\u2009±\u20091.6, p\u2009=\u20090.01). Cardiac re-operations worsened survival. Conclusion ECMO is a viable rescue strategy for cardiac surgery patients with a 40% survival to discharge rate. Careful attention to volume management and blood transfusion are important markers for potential survival.